Weiss Multi-Strategy Advisers’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,115
Closed -$634K 242
2023
Q4
$634K Sell
3,115
-818
-21% -$133K 0.02% 466
2023
Q3
$780K Buy
3,933
+2,155
+121% +$543K 0.02% 452
2023
Q2
$577K Sell
1,778
-188
-10% -$53.7K 0.01% 571
2023
Q1
$460K Sell
1,966
-5
-0.3% -$1.26K 0.01% 561
2022
Q4
$496K Sell
1,971
-29
-1% -$6.18K 0.01% 515
2022
Q3
$355K Sell
2,000
-2,167
-52% -$435K 0.01% 579
2022
Q2
$761K Sell
4,167
-915
-18% -$182K 0.02% 510
2022
Q1
$1.3M Buy
5,082
+40
+0.8% +$9.14K 0.03% 463
2021
Q4
$1.16M Sell
5,042
-20
-0.4% -$4.88K 0.03% 456
2021
Q3
$1.18M Sell
5,062
-144
-3% -$30K 0.03% 484
2021
Q2
$1.01M Buy
5,206
+185
+4% +$36.7K 0.02% 488
2021
Q1
$1.04M Sell
5,021
-141
-3% -$30K 0.02% 476
2020
Q4
$971K Buy
+5,162
New +$844K 0.02% 494

Other funds holding INSP

Weiss Multi-Strategy Advisers's INSP Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 3,115 shares — an estimated $634K sold.

Weiss Multi-Strategy Advisers first reported a position in INSP in Q4 2020 and held it in 13 quarters. The position peaked at $1.3M in Q1 2022. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 3,115 Inspire Medical Systems shares in Q1 2024, an estimated $634K.
  • Weiss Multi-Strategy Advisers first reported a position in Inspire Medical Systems in Q4 2020 and held it in 13 quarters.
  • Weiss Multi-Strategy Advisers's Inspire Medical Systems position peaked at $1.3M in Q1 2022.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.